Startups
Translate Bio
https://translate.bio/Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.
Summary
Total Funding
$183M
- Unknown (2019-05-03) $47.5M
- Series C (2017-01-10) $51.0M
- Series B (2015-07-30) $63.8M
- Series A (2012-01-18) $20.7M
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable